Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

BID Antikörper (C-Term)

Der Ziege Polyklonal anti-BID Antikörper wird verwendet zum Nachweis von BID in Proben von Human. Er wurde validiert für WB und EIA.
Produktnummer ABIN374543
772,31 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für BID Antikörper (C-Term) (ABIN374543)

Target

Alle BID Antikörper anzeigen
BID (BH3 Interacting Domain Death Agonist (BID))

Reaktivität

  • 166
  • 76
  • 39
  • 2
  • 2
  • 1
Human

Wirt

  • 173
  • 26
  • 2
  • 1
Ziege

Klonalität

  • 143
  • 59
Polyklonal

Konjugat

  • 101
  • 19
  • 12
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Dieser BID Antikörper ist unkonjugiert

Applikation

  • 171
  • 83
  • 58
  • 52
  • 36
  • 29
  • 27
  • 27
  • 26
  • 25
  • 7
  • 6
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 20
    • 18
    • 16
    • 8
    • 8
    • 7
    • 7
    • 5
    • 5
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Sequenz

    C-TYVRSLARNG MD

    Spezifität

    This antibody reacts to BH3-interacting domain death agonist. It is expected to recognise all three reported isoforms (as represented by NP_932070.1, NP_001187.1, NP_932071.1)

    Kreuzreaktivität (Details)

    Species reactivity (tested):Human.

    Aufreinigung

    Affinity Chromatography

    Immunogen

    Peptide with sequence from the C Terminus of the protein sequence according to NP_932070.1, NP_001187.1, NP_932071.1. Genename: BID
  • Applikationshinweise

    Peptide ELISA: 1/8000. Western Blot: 0.1 - 0.3 μg/mL.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Tris saline, pH ~7.3 containing 0.02 % Sodium Azide and 0.5 % BSA

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    4 °C/-20 °C

    Informationen zur Lagerung

    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target

    BID (BH3 Interacting Domain Death Agonist (BID))

    Andere Bezeichnung

    BID

    Hintergrund

    Bid, a BH3 domain containing proapoptotic Bcl2 family member, is localized in the cytosolic fraction of cells as an inactive precursor. Its active form is generated upon proteolytic cleavage by caspase 8 in the Fas signaling pathway. Cleaved Bid translocates to mitochondria and releases its potent proapoptotic activity, which in turn induces cytochrome c release and mitochondrial damage. The cytochrome c releasing activity of Bid was antagonized by Bcl2. Mutation in the SH3 domain can diminish the cytochrome c releasing activity. In animal model studies, Bid deficient mice are found resistant to the lethal effects of death factor signals relayed through Fas.Synonyms: BH3-interacting domain death agonist, p22 BID

    Molekulargewicht

    26.8kDa (NP_932070.1) and 22.0kDa (NP_001187.1).

    Gen-ID

    637, 9606

    UniProt

    P55957

    Pathways

    Apoptose, Caspase Kaskade in der Apoptose, Positive Regulation of Endopeptidase Activity
Sie sind hier:
Chat with us!